Patent · US Active

Marker sequences for the diagnosis and stratification of systemic sclerosis patients

US10677795B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Protagen AG · DE

Inventors

Petra BUDDE · Dortmund, DE
Dieter ZUCHT · Hannover, DE
Angelika Lüking · Bochum, DE
Matthias Schneider · Dossenheim, DE

Key dates

Filing date	May 11, 2015
Grant date	Jun 9, 2020
Priority date	—
Expiry date	Sep 25, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to methods for identifying markers for systemic sclerosis (also referred to as scleroderma; SSc) and the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices, and test kits which comprise these markers, and also to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc subgroups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.